Live tape
Top 8, mentions 7d29,589NVDA13,994 mentions▲ +0.04ANT4,251 mentions▲ +0.07GOOGL3,042 mentions▲ +0.04SPY2,327 mentions▲ +0.05QQQ1,837 mentions▲ +0.04SPCX1,585 mentions▲ +0.07AMD1,371 mentions▲ +0.06AAPL1,182 mentions▲ +0.04

Equity · Healthcare

CRSP

NASDAQ

CRISPR Therapeutics (CRSP)

39.16 USD +0.75% vs prior close Nov 20, 2026
CRISPR Therapeutics AG price graph
64 sessions
70 30 24 Aug 20 Nov

The line runs 57 USD on 24 August through 39.16 USD on 20 November, on a scale from 30 to 70. Days the market did not trade hold the previous close, flat.

Market cap
3.8B USD
Revenue, year to Dec 2025
3.5M USD
EPS, diluted, year to Dec 2025
−6.47 USD
52-week range
38.87 USD – 61.91 USD
Avg volume
83.2K
Mentions, 30 days
13
Net sentiment
+0.05

as of Nov 20, 2026

Have CRISPR Therapeutics (CRSP) insiders bought or sold shares recently?

In the 90 days to 23 Nov 2026, CRISPR Therapeutics insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 18 Dec 2025, show no open-market purchase.

Form 4, 90 days to 23 Nov 2026, newest reported trade 19 Oct 2026

0buys
7sells
$4.88Mnet sold
8other filings
Have CRISPR Therapeutics (CRSP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
19 Oct 2026Kulkarni SamarthChief Executive OfficerSell47,8372.4M USD
14 Oct 2026George SimeonDirectorSell14,514720K USD
14 Oct 2026KASINGER JAMES R.General Counsel and SecretarySell1,04051K USD
14 Oct 2026Kulkarni SamarthChief Executive OfficerSell4,098202K USD
06 Oct 2026KASINGER JAMES R.General Counsel and SecretarySell1,990119K USD
22 Sep 2026KASINGER JAMES R.General Counsel and SecretarySell10,400626K USD
17 Sep 2026Behbahani AliDirectorSell13,679781K USD
Sold7 open-market sales93,558$4.88M
8 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have CRISPR Therapeutics (CRSP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Nov 2026Kulkarni SamarthChief Executive OfficerGift100,000
16 Oct 2026Kulkarni SamarthChief Executive OfficerOption exercise100,000
14 Oct 2026George SimeonDirectorOption exercise30,000420K USD
13 Oct 2026KASINGER JAMES R.General Counsel and SecretaryOption exercise2,113
13 Oct 2026Kulkarni SamarthChief Executive OfficerOption exercise8,333
06 Oct 2026KASINGER JAMES R.General Counsel and SecretaryOption exercise1,99027K USD
22 Sep 2026KASINGER JAMES R.General Counsel and SecretaryOption exercise10,400142K USD
17 Sep 2026Behbahani AliDirectorOption exercise30,000420K USD

Which funds hold CRISPR Therapeutics (CRSP)?

9 of the 45 institutional funds we track reported a CRISPR Therapeutics position for the quarter ended 30 Sep 2026 — a combined 729.1M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold CRISPR Therapeutics (CRSP)?
FundPositionSharesValueShares q/q
ARK Investment ManagementHeld (±25%)10,056,844556.3M USD+6.3%
Two Sigma InvestmentsHeld (±25%)2,016,038111.5M USD+1.4%
D. E. Shaw & Co.Trimmed518,90628.7M USD−41.9%
Man GroupAdded329,60218.2M USD+350.3%
Millennium ManagementTrimmed91,6305.1M USD−76.0%
Fisher Asset ManagementHeld (±25%)67,3023.7M USD−13.7%
Tudor Investment CorpHeld (±25%)52,5202.9M USD+23.5%
AQR Capital ManagementAdded41,9072.3M USD+46.5%
Citadel AdvisorsTrimmed4,680259K USD−99.0%

Have members of Congress traded CRISPR Therapeutics (CRSP)?

The most recent congressional trade disclosed in CRISPR Therapeutics is a purchase by Thomas R. Suozzi (house, NY), dated 03 Jun 2021.

STOCK Act disclosures

Have members of Congress traded CRISPR Therapeutics (CRSP)?
TradedMemberTypeAmountFiled after
03 Jun 2021Thomas R. Suozzihouse · Democrat–NYPurchase50K USD–100K USD112 days

What has been filed or recorded for CRISPR Therapeutics (CRSP)?

The filings we hold for CRISPR Therapeutics, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for CRISPR Therapeutics (CRSP)?
And
30 Oct 2026Fails to deliverShares failed to deliver1,718 shares93K USD notional · 0.002% of shares out
28 Oct 2026Fails to deliverShares failed to deliver293 shares15K USD notional · <0.001% of shares out
27 Oct 2026Fails to deliverShares failed to deliver64 shares3K USD notional · <0.001% of shares out
21 Oct 2026Fails to deliverShares failed to deliver68 shares3K USD notional · <0.001% of shares out
20 Oct 2026Fails to deliverShares failed to deliver4,084 shares204K USD notional · 0.004% of shares out
19 Oct 2026Fails to deliverShares failed to deliver30,328 shares1.5M USD notional · 0.031% of shares out
16 Oct 2026Fails to deliverShares failed to deliver4,898 shares252K USD notional · 0.005% of shares out
15 Oct 2026Fails to deliverShares failed to deliver37,286 shares1.9M USD notional · 0.038% of shares out
09 Oct 2026Fails to deliverShares failed to deliver9,578 shares483K USD notional · 0.010% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −1.15 USD
30 Sep 2026FinancialsTotal assets2.6B USDat period end
30 Sep 2026FinancialsTotal equity1.6B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.94 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −1.28 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −6.47 USD
31 Dec 2025FinancialsRevenue3.5M USDfiscal year
31 Dec 2025FinancialsNet income−581.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−6.47 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −1.17 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −2.40 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −1.58 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −4.34 USD

What is Reddit saying about CRISPR Therapeutics (CRSP)?

Reddit mentioned CRSP 13 times in the 30 days to 22 November 2026, across 4 of the communities we track. All of them were scored for sentiment: 46% read bullish, 23% bearish and 31% neither. Reddit data updated 22 November 2026.

30-day window, Method

13mentions, 30 days
46%bullish
23%bearish
4communities
−6pointsagainst the market

How do Reddit mentions of CRISPR Therapeutics (CRSP) compare with its price?

Share ↗
13 mentions

Which subreddits are talking about CRISPR Therapeutics (CRSP)?

30 days

Which subreddits are talking about CRISPR Therapeutics (CRSP)?
CommunityShareMentionsNet sentiment
r/wallstreetbets77%10+0.05
r/etfs8%1+0.01
r/stocks8%1+0.03
r/investing8%1+0.09

Which names move with CRISPR Therapeutics (CRSP) on Reddit?

6 names, 30 days

JNJ moved most closely with CRISPR Therapeutics (CRSP): when the crowd talked about one, it talked about the other (+0.63 over 31 days). Co-discussion, not price.

How closely CRSP's daily Reddit mentions moved with each name, 30 days
International Monetary Fund
Medicare
CRSP
+0.63+0.63+0.60+0.60+0.60+0.59
View the matrix as a tableHide the table
Names that move with CRSP on Reddit, 30 days
PairMatchDays measured
CRSP and JNJ+0.6331 days
CRSP and CME+0.6331 days
CRSP and International Monetary Fund+0.6031 days
CRSP and Medicare+0.6031 days
CRSP and RPG+0.6031 days
CRSP and LRCX+0.5931 days

What do people ask about CRISPR Therapeutics (CRSP)?

From live data
What did CRISPR Therapeutics shares close at?39.16

CRISPR Therapeutics closed at 39.16 USD on 20 Nov 2026, up 0.75% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is CRISPR Therapeutics’ market cap?3.8B

CRISPR Therapeutics is worth 3.8B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is CRISPR Therapeutics’ revenue?3.5M

CRISPR Therapeutics reported revenue of 3.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have CRISPR Therapeutics insiders bought or sold shares recently?7 sales

In the 90 days to 23 Nov 2026, CRISPR Therapeutics insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 18 Dec 2025, show no open-market purchase. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own CRISPR Therapeutics?9 of 45

9 of the 45 funds we track reported a CRISPR Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were ARK Investment Management, Two Sigma Investments and D. E. Shaw & Co. See Funds

Have members of Congress traded CRISPR Therapeutics?1 trade

Yes. 1 trade in CRISPR Therapeutics appears in the congressional disclosures we hold: a purchase by Thomas R. Suozzi (House, NY) dated 3 Jun 2021, filed 23 Sep 2021. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did CRISPR Therapeutics last report earnings?−1.15

CRISPR Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −1.15 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about CRISPR Therapeutics?4 mentions

CRISPR Therapeutics was mentioned 4 times in the last 7 days across the finance subreddits we track, and 13 times over the trailing 30 days. Of the 13 mentions scored for sentiment, 46% read bullish and 23% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. Wikimedia CommonsPortraits via Wikimedia Commons. Thomas R. Suozzi: Österreichisches Außenministerium (BMEIA/ Michael Gruber), CC BY 4.0.
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SECSEC fails-to-deliver (CNS) data
  9. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  10. SEC EDGARreported earnings figures and scheduled report dates
  11. SEC EDGARValuation computed from SEC EDGAR filings
  12. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words